Evidence map›Paper›PMID 34228236›Full record

ArticleEJNMMI radiopharmacy and chemistry2021

GMP-compliant production of [

Marc Pretze, Laura Reffert, Steffen Diehl, Stefan O Schönberg, Carmen Wängler, Peter Hohenberger, Björn Wängler

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Preclinical Evaluation of aACS pharmacology & translational science · 2026
    Article
  2. Review
  3. Pharmaceutics · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. [European journal of nuclear medicine and molecular imaging · 2022
    Article
  8. Review
  9. Cold Kit Labeling: The Future ofFrontiers in medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marc PretzeDepartment of Nuclear Medicine, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany. Marc.Pretze@uniklinikum-dresden.de.ORCID http://orcid.org/0000-0002-6432-5694
Laura ReffertDepartment of Nuclear Medicine, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Steffen DiehlDepartment of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Mannheim, Germany.
Stefan O SchönbergDepartment of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Mannheim, Germany.
Carmen WänglerBiomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
Peter HohenbergerDivision of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany.
Björn WänglerMolecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. Bjoern.Waengler@medma.uni-heidelberg.de.
Heidelberg University · DEUniversity Hospital Carl Gustav Carus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background[

resultsValidation of the production and quality control of [

conclusionsA fully GMP compliant kit preparation of [

Indexed as

[68Ga]Ga-NeoBGMPGRPRMetastatic GISTPET/CT

Identifiers

PMID34228236
PMCPMC8260665
OpenAlexW3159252641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.